四環醫藥(00460.HK)及瑞麗醫美(02135.HK)隨A股同業漲8%-22%
滬指及深成今天逆區內股市反覆微升0.1%-0.3%。板塊方面,除銀行升2.1%外,流感、醫藥生物、病毒防治、醫療器械、生物疫苗及醫療美容更依次升2.4%-6.7%。
本港相關股除旗下四項研究入選美國臨床腫瘤學會年會的亞盛醫藥(06855.HK)急漲12%曾高見36.4元外;四環醫藥(00460.HK)於最近八個交易除上周四回吐外,其餘股價均漲,今天更逆市升破2月下旬所創52周高位3.12元,午後高見3.2元,創近四年高,現造3.16元,續漲8.2%,成交仍達2.2億股,涉資6.73億元。
另外,去年12月尾才以每股0.4元來港上市的內地浙江省領先醫療美容服務提供商瑞麗醫美(02135.HK)更急漲222%報0.495元,逼近去年尾所創上市高位0.51元,成交倍增至4,088萬股。
必瘦站(01830.HK)四連漲兼連續第三天創紀錄高,最高見7.66元,現報7.45元,續升3.9%,成交584萬股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.